Mitral annular calcification and the serum osteocalcin level in patients with chronic kidney disease

References

• Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296–1305
   PubMed Web of Science ®Google Scholar
• Dellegrottaglie S, Sanz J, Rajagopalan S. Vascular calcification in patients with chronic kidney disease. Blood Purif. 2006;24:56–62
   Google Scholar
• Kestenbaum B, Belozeroff V. Mineral metabolism disturbances in patients with chronic kidney disease. Eur J Clin Invest. 2007;37:607–622
   PubMed Web of Science ®Google Scholar
• Bellasi A, Ferramosca E, Ratti C, Block G, Raggi P. Cardiac valve calcification is a marker of vascular disease in prevalent hemodialysis patients. J Nephrol. 2012;25:211–218
   PubMed Web of Science ®Google Scholar
• Fox CS, Parise H, Vasan RS, et al. Mitral annular calcification is a predictor for incident atrial fibrillation. Atherosclerosis. 2004;173:291–294
   PubMed Web of Science ®Google Scholar
• Fox CS, Vasan RS, Parise H, et al. Mitral annular calcification predicts cardiovascular morbidity and mortality: The Framingham Heart Study. Circulation. 2003;107:1492–1496
   PubMed Web of Science ®Google Scholar
• Chenu C, Colucci S, Grano M, et al. Osteocalcin induces chemotaxis, secretion of matrix proteins, and calcium-mediated intracellular signaling in human osteoclast-like cells. J Cell Biol. 1994;127:1149–1158
   PubMed Web of Science ®Google Scholar
• Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007;130:456–469
   PubMed Web of Science ®Google Scholar
• Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA. 2008;105:5266–5270
   PubMed Web of Science ®Google Scholar
• Yamada S, Inaba M, Kurajoh M, et al. Utility of serum tartrate-resistant acid phosphatase (TRACP5b) as a bone resorption marker in patients with chronic kidney disease: Independence from renal dysfunction. Clin Endocrinol. 2008;69:189–196
   PubMed Web of Science ®Google Scholar
• Pomerance A. Pathological and clinical study of calcification of the mitral valve ring. J Clin Pathol. 1970;23:354–361
   Google Scholar
• Simon MA, Liu SF. Calcification of the mitral valve annulus and its relation to functional valvular disturbance. Am Heart J. 1954;48:497–505
   PubMed Web of Science ®Google Scholar
• Mellino M, Salcedo EE, Lever HM, Vasudevan G, Kramer JR. Echographic-quantified severity of mitral anulus calcification: Prognostic correlation to related hemodynamic, valvular, rhythm, and conduction abnormalities. Am Heart J. 1982;103:222–225
   Web of Science ®Google Scholar
• Soeki T, Fukuda N, Shinohara H, et al. Mitral inflow and mitral annular motion velocities in patients with mitral annular calcification: Evaluation by pulsed Doppler echocardiography and pulsed Doppler tissue imaging. Eur J Echocardiogr. 2002;3:128–134
   Google Scholar
• Sayarlioglu H, Acar G, Sahin M, et al. Prevalence and risk factors of valvular calcification in hemodialysis patients. Iran J Kidney Dis. 2013;7:129–134
   Google Scholar
• Varol E, Aksoy F, Ozaydin M, Erdogan D, Dogan A. Association between neutrophil-lymphocyte ratio and mitral annular calcification. Blood Coagul Fibrinolysis. 2014;25:557–560
   PubMed Web of Science ®Google Scholar
• Adeney KL, Siscovick DS, Ix JH, et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol. 2009;20:381–387
   PubMed Web of Science ®Google Scholar
• Kanbay M, Wolf M, Selcoki Y, et al. Association of serum calcitonin with coronary artery disease in individuals with and without chronic kidney disease. Int Urol Nephrol. 2012;44:1169–1175
   PubMed Web of Science ®Google Scholar
• Janda K, Krzanowski M, Gajda M, Dumnicka P, et al. Impaired fasting glucose and diabetes as predictors for radial artery calcification in end stage renal disease patients. Int J Endocrinol. 2013;2013:969038
   PubMed Web of Science ®Google Scholar
• Krzanowski M, Janda K, Dumnicka P, et al. Relationship between aortic pulse wave velocity, selected proinflammatory cytokines, and vascular calcification parameters in peritoneal dialysis patients. J Hypertens. 2014;32:142–148
   Google Scholar
• Yamashita T, Okano K, Tsuruta Y, et al. Serum osteocalcin levels are useful as a predictor of cardiovascular events in maintenance hemodialysis patients. Int Urol Nephrol. 2013;45:207–214
   Google Scholar
• Kanazawa I, Yamaguchi T, Yamamoto M, et al. Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2009;94:45–49
   PubMed Web of Science ®Google Scholar
• Avila-Diaz M, Mora-Villalpando C, Prado-Uribe Mdel C, et al. De novo development of heart valve calcification in incident peritoneal dialysis patients. Arch Med Res. 2013;44:638–644
   Google Scholar
• Osorio A, Ortega E, Torres JM, Sanchez P, Ruiz-Requena E. Biochemical markers of vascular calcification in elderly hemodialysis patients. Mol Cell Biochem. 2013;374:21–27
   Google Scholar
• Osorio A, Ortega E, Torres JM, Sanchez P, Ruiz-Requena E. Mineral-bone metabolism markers in young hemodialysis patients. Clin Biochem. 2011;44:1425–1428
   Google Scholar
• Bacchetta J, Boutroy S, Guebre-Egziabher F, et al. The relationship between adipokines, osteocalcin and bone quality in chronic kidney disease. Nephrol Dial Transplant. 2009;24:3120–3125
   PubMed Web of Science ®Google Scholar